Bank of America’s AN2 Therapeutics ANTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $409K | Buy |
385,511
+28
| +0% | +$30 | ﹤0.01% | 4915 |
|
|
2025
Q1 | $524K | Buy |
385,483
+8
| +0% | +$11 | ﹤0.01% | 4705 |
|
|
2024
Q4 | $532K | Buy |
385,475
+369,265
| +2,278% | +$510K | ﹤0.01% | 4661 |
|
|
2024
Q3 | $17.3K | Buy |
16,210
+574
| +4% | +$614 | ﹤0.01% | 5864 |
|
|
2024
Q2 | $33.6K | Buy |
15,636
+664
| +4% | +$1.43K | ﹤0.01% | 5755 |
|
|
2024
Q1 | $48.7K | Sell |
14,972
-6,922
| -32% | -$22.5K | ﹤0.01% | 5653 |
|
|
2023
Q4 | $449K | Buy |
21,894
+18,799
| +607% | +$385K | ﹤0.01% | 4693 |
|
|
2023
Q3 | $49.8K | Sell |
3,095
-9,121
| -75% | -$147K | ﹤0.01% | 5615 |
|
|
2023
Q2 | $104K | Sell |
12,216
-13,700
| -53% | -$116K | ﹤0.01% | 5339 |
|
|
2023
Q1 | $256K | Buy |
25,916
+1,202
| +5% | +$11.9K | ﹤0.01% | 5025 |
|
|
2022
Q4 | $236K | Buy |
24,714
+11,548
| +88% | +$110K | ﹤0.01% | 5105 |
|
|
2022
Q3 | $229K | Buy |
13,166
+11,527
| +703% | +$200K | ﹤0.01% | 5121 |
|
|
2022
Q2 | $13K | Buy |
+1,639
| New | +$13K | ﹤0.01% | 6489 |
|